Arcturus Therapeutics Holdings Inc. 10-Q filing
Filed 2025-08-11 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-106560
- Form type
- 10-Q
- CIK
- 0001768224
- Primary document
- https://www.sec.gov/Archives/edgar/data/1768224/000095017025106560/arct-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Arcturus Therapeutics Holdings Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $57.7M | - | - |
| Operating Income | $-28.4M | - | - |
| Net Income | $-23.3M | - | - |
| Eps Basic | -0.86 | - | - |
| Eps Diluted | -0.86 | - | - |
| Cash And Equivalents | $196.5M | - | - |
| Total Assets | $309.3M | - | - |
| Total Liabilities | $78.2M | - | - |
| Shareholders Equity | $231.1M | - | - |
| Operating Cash Flow | $-40.9M | - | - |
| Capital Expenditures | $137,000 | - | - |